Form 4: HCA Healthcare Executive Jennifer Berres Awarded Stock Appreciation Rights

HCA Healthcare's Senior Vice President and Chief Human Resources Officer, Jennifer Berres, was granted 8,490 stock appreciation rights on January 28, 2025.

Summary

• Jennifer Berres, a Senior Vice President and Chief Human Resources Officer at HCA Healthcare, was granted 8,490 stock appreciation rights on January 28, 2025.
• These rights vest in four equal annual installments starting on January 28, 2026.
• The stock appreciation rights are based on HCA Healthcare's common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns executive interests with shareholder value. There are no negative implications.

Positives

• The granting of stock appreciation rights aligns the executive's interests with the company's performance.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The stock appreciation rights will vest over four years, incentivizing the executive to contribute to the company's long-term success.

Industry Context

Stock-based compensation is a common practice in the healthcare industry to attract and retain top executive talent.

Comparison to Industry Standards

• Stock appreciation rights are a common form of equity compensation used by large publicly traded companies like HCA Healthcare.
• Companies such as Tenet Healthcare and Universal Health Services also use similar equity-based incentives for their executives.
• The vesting schedule of four years is also typical for these types of awards.

Stakeholder Impact

• The stock appreciation rights align the executive's interests with those of shareholders, potentially leading to increased company value.
• The vesting schedule may encourage the executive to focus on long-term strategic goals.

Key Dates

Keywords

stock appreciation rights, HCA Healthcare, executive compensation, Jennifer Berres, equity, vesting